GUMM - why this is so significant. The release of Zicam will no doubt be a huge windfall for several reasons,some of which are "duh-obvious".
1.Americans spend billions of dollars on cold remedies. The amount of
other cold remedies needed will decrease, so individuals may
actually save money by using Zicam.
2. For many hospitalized people, relatively bland infections such as the common cold are the precursors to so-called secondary infections that kill them. Immunosuppressed patients include AIDS patients,cancer patients both before & during chemotherapy, people with autoimmune diseases and transplant patients who undergo immunosuppression to allow their bodies accept/keep grafts. This medicine has the potential to save them from these bland "primary" infections, so that the secondary infections do not occur. This has the potential, frankly, of saving lives, not to mention the savings in the expensive drugs needed to treat secondary infections (usually intravenous, usually very xpensive, and also with toxicities of their own).
3. Many strains of viruses cause the "common cold". The reason why no good vaccinations xist is because the viruses are different and thus many,many vaccines would be necessary. Also, vaccines are directed against viral antigens that may change by mutation. Zicam works by blocking the receptor to which most viruses attach. Therefore, the extent of infection is inherently limited by using Zicam.
Note: I have an investment position in this company and my comments are
given only as an investor, not as a physician dispensing medical
advice.Each person is responsible for his or her own investment
decisions.
|
